Connection

Jean-Charles Soria to Cetuximab

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Cetuximab.
Jean-Charles Soria
Connection Strength
0.091
Cetuximab
  1. A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours. Eur J Cancer. 2018 11; 104:1-8.
    View in: PubMed
    Score: 0.047
  2. Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours. Eur J Cancer. 2017 08; 81:81-89.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.